Pharmaceutical Industry Every Fifth Pharma–Dollar is Made in Developing Markets

Editor: Dominik Stephan

More than half the leading pharmaceutical decision makers expect that the developing countries will account for around 30% of the global pharmaceutical turnovers.

Related Companies

How managers of pharmaceutical companies plant to enter the devloping markets.
How managers of pharmaceutical companies plant to enter the devloping markets.
(Picture: PROCESS)

A recent study by Booz & Co sees a distinctive trend to tap into these markets with local sales, R&D or manufacturing subsidiaries. Currently, the pharmaceutical industry gains around US $ 191 billion in these markets – Roughly one fifth of the total global market volume.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:38954030)